Enterprise Value
$83.78 B
+$450.55 M+0.54%
Thu, 28 Nov 2024 00:58:06 GMT
Summary:
Regeneron Pharmaceuticals enterprise value is currently $83.78 billion, with a rise of +$450.55 million (+0.54%) during the most recent trading day. Over the past year, it has dropped by -$3.44 billion (-3.94%). REGN enterprise value is now -37.00% below its all-time high of $132.99 billion.REGN Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
REGN Enterprise Value Performance
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | +0.5% | +0.6% | +0.6% |
| 1 m1 month | -16.5% | -18.8% | -18.8% |
| 3 m3 months | -36.9% | -37.1% | -36.9% |
| 6 m6 months | -22.9% | -23.4% | -23.2% |
| ytdytd | -12.5% | -13.2% | -13.6% |
| 1 y1 year | -3.9% | -4.1% | -5.0% |
| 5 y5 years | +108.8% | +103.7% | +103.5% |
REGN Enterprise Value High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | $103 B | -19.0% | $82 B | +2.2% |
| 3 m | 3 months | $133 B | -37.0% | $82 B | +2.2% |
| 6 m | 6 months | $133 B | -37.0% | $82 B | +2.2% |
| 1 y | 1 year | $133 B | -37.0% | $82 B | +2.2% |
| 3 y | 3 years | $133 B | -37.0% | $60 B | +40.6% |
| 5 y | 5 years | $133 B | -37.0% | $36 B | +131.6% |
| alltime | all time | $133 B | -37.0% | $45 M | >+9999.0% |
Regeneron Pharmaceuticals Enterprise Value History
| Date | Value |
|---|---|
| 2024 | $83.78 B(-12.5%) |
| 2023 | $95.73 B(+21.6%) |
| 2022 | $78.73 B(+15.0%) |
| 2021 | $68.44 B(+31.2%) |
| 2020 | $52.17 B(+28.8%) |
| 2019 | $40.50 B(+1.4%) |
| 2018 | $39.95 B(-1.0%) |
| 2017 | $40.35 B(+3.8%) |
| 2016 | $38.86 B(-31.1%) |
| 2015 | $56.36 B(+34.7%) |
| 2014 | $41.83 B(+52.6%) |
| 2013 | $27.41 B(+62.5%) |
| 2012 | $16.87 B(+231.1%) |
| 2011 | $5.10 B(+70.8%) |
| 2010 | $2.98 B(+60.1%) |
| 2009 | $1.86 B(+53.4%) |
| 2008 | $1.21 B(-24.3%) |
| Date | Value |
|---|---|
| 2007 | $1.61 B(+25.9%) |
| 2006 | $1.27 B(+39.6%) |
| 2005 | $912.88 M(+47.4%) |
| 2004 | $619.25 M(-32.2%) |
| 2003 | $912.86 M(-3.3%) |
| 2002 | $943.83 M(-20.8%) |
| 2001 | $1.19 B(-6.2%) |
| 2000 | $1.27 B(+233.2%) |
| 1999 | $381.04 M(+78.8%) |
| 1998 | $213.16 M(-11.7%) |
| 1997 | $241.47 M(-37.8%) |
| 1996 | $388.23 M(+52.1%) |
| 1995 | $255.20 M(+463.5%) |
| 1994 | $45.29 M(-84.2%) |
| 1993 | $287.24 M(+64.5%) |
| 1992 | $174.64 M(-31.5%) |
| 1991 | $255.05 M |
FAQ
- What is Regeneron Pharmaceuticals enterprise value?
- What is the all time high enterprise value for Regeneron Pharmaceuticals?
- What is REGN enterprise value year-to-date change?
- What is Regeneron Pharmaceuticals enterprise value year-on-year change?
What is Regeneron Pharmaceuticals enterprise value?
The current enterprise value of REGN is $83.78 B
What is the all time high enterprise value for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high enterprise value is $132.99 B
What is REGN enterprise value year-to-date change?
Regeneron Pharmaceuticals enterprise value has changed by -$11.95 B (-12.48%) since the beginning of the year
What is Regeneron Pharmaceuticals enterprise value year-on-year change?
Over the past year, REGN enterprise value has changed by -$3.44 B (-3.94%)